Cargando…
Recent developments and translational aspects in targeted therapy for metastatic breast cancer
Biologically distinct subtypes of metastatic breast cancer (MBC) have been defined by multiple efforts in recent years, showing broad heterogeneity at the molecular level of disease. Throughout this endeavour, oncogenic drivers within MBC were identified as potential therapeutic targets. With recent...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070263/ https://www.ncbi.nlm.nih.gov/pubmed/27843605 http://dx.doi.org/10.1136/esmoopen-2016-000036 |